Mydoeln-10 ® Capsules
(Lenalidomide 10mg)


GENERIC NAME: Lenalidomide 10mg Capsules
THERAPEUTIC CLASS: Immunomodulatory agents
INDICATIONS & DOSAGE:
- Multiple myeloma (MM), in combination with dexamethasone, in patients who have received at least one prior therapy
- Transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q abnormality with or without additional cytogenetic abnormalities
- Mantle cell lymphoma (MCL) whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib
STORAGE: Store below 30°C. Protect from sunlight.
PACK SIZE: 1×1’s
DOSAGE & ADMINISTRATION:
MM: 25 mg once daily orally on Days 1-21 of repeated 28-day cycles.
Recommended dose of dexamethasone is 40 mg once daily on Days 1-4, 9-12, and 17-20 of each 28-day cycle for the first 4 cycles of therapy and then 40 mg/day orally on Days 1-4 every 28 days
- MDS: 10 mg once daily
- MCL: 25 mg once daily orally on Days 1-21 of repeated 28-day cycles
- Continue or modify dosing based on clinical and laboratory findings
- Renal impairment: Adjust starting dose in patients with moderate or severe renal impairment and on dialysis